Annual report pursuant to Section 13 and 15(d)

10. Stock-based Compensation

v3.6.0.2
10. Stock-based Compensation
12 Months Ended
Sep. 30, 2016
Share-based Compensation [Abstract]  
Stock-based Compensation

From time to time, the Company grants stock options and restricted stock awards to directors, officers and employees. These awards are valued at the grant date by determining the fair value of the instruments, net of estimated forfeitures. The value of each award is amortized on a straight-line basis over the requisite service period.

 

Stock Options

 

The following table summarizes stock option activity for the years ended September 30, 2016 and 2015:

 

          Weighted     Weighted        
          Average     Average        
    Number of     Exercise     Remaining        
  Shares     Price     Contractual Life     Intrinsic Value  
Outstanding at September 30, 2015     175,000     $ 11.22       4.76     $ 225,750  
Granted                              
Exercised                              
Forfeited                              
Outstanding at September, 30 2016     175,000     $ 11.22       3.75     $ 346,500  
Exercisable at September 30, 2016     168,750     $ 10.68       3.55     $ 346,500  

 

The Company recognized compensation expense of $256,145 and $712,538 during the years ended September 30, 2016 and 2015, respectively, related to stock option awards granted to certain employees and officers based on the grant date fair value of the awards, net of estimated forfeitures.

 

At September 30, 2016 the Company had $3,653 of unrecognized compensation expense (net of estimated forfeitures) associated with stock option awards which the company expects will be recognized through June of 2017.

 

During the year ended September 30, 2015, the Company reduced the exercise price by 50% for the 100,000 stock options then outstanding. The Company recognized compensation expense of $54,677 related to the re-pricing of the exercise price for these options.

 

The exercise price for stock options outstanding and exercisable at September 30, 2016 is as follows:

 

Outstanding     Exercisable  
Number of
Options
    Exercise
Price
    Number of
Options
    Exercise
Price
 
  31,250     $ 4.98       31,250     $ 4.98  
  25,000       7.50       25,000       7.50  
  31,250       10.02       31,250       10.02  
  6,250       12.48       6,250       12.48  
  6,250       15.00             15.00  
  75,000       15.18       75,000       15.18  
  175,000               168,750          

 

The following table summarizes information about the Company’s non-vested shares as of September 2016:

 

          Weighted-Average  
    Number of     Grant-Date  
Non-vested Shares   Shares     Fair Value  
Non-vested at September 30, 2015     62,500     $ 8.64  
Granted              
Vested     (56,250 )        
Non-vested at September 30, 2016     6,250     $ 8.64  

 

For stock options granted during 2015 where the exercise price equaled the stock price at the date of the grant, the weighted-average fair value of such options was $11.52 and the weighted-average exercise price of such options was $15.18. No options were granted during 2016 and 2015, where the exercise price was less than the common stock price at the date of grant or where the exercise price was greater than the common stock price at the date of grant.

 

The assumptions used in calculating the fair value of stock options granted use the Black-Scholes option pricing model for options granted in 2015 are as follows:

 

Risk-free interest rate   1.01%
Expected life of the options   2.5 to 3.5 years
Expected volatility   140%
Expected dividend yield   0%